Contact Us
×Thank you for taking the time to help us improve the Console.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Loading...
Responsive COVID-19 Vaccines for Recovery Project under the Asia Pacific Vaccine Access Facility
Sectors
Issues Raised
Project Information
Investment ID: 4083-SRI
Bank: Asian Development Bank
Environmental Category: B
Country: Sri Lanka
Region: South Asia
Approval Date: July 8, 2021
Investment Types: Loans
Total Project Cost: USD 95.9 million
Total Complaints: 2
Description
The project will provide the Government of Sri Lanka with immediate and flexible financing to support the national COVID-19 vaccination program through APVAX and the regular country allocation. The APVAX allocation comprises a rapid response component (RRC) to support the purchase of Asian Development Bank (ADB) eligible COVID-19 vaccines, while the project investment component (PIC) financed by the regular country allocation will support strengthening of the vaccination information dissemination and monitoring systems, vaccine transportation capacity, and vaccine-related medical waste management.
Investments
| Investment Type | ID | Amount | Status | Bank | Client |
|---|---|---|---|---|---|
| Loans | 4083-SRI | USD 84.0 million | Planned | ADB |
Related Complaints
| Asian Development Bank SPF CRP Complaints | IAM | Country | Date Filed | Status |
|---|---|---|---|---|
| Responsive COVID-19 Vaccination for Recovery Project under the Asia Pacific Vaccine Access Facility | ADB SPF CRP | Maldives | 28/08/2023 | Closed Without Outputs |
| Responsive COVID-19 Vaccines for Recovery Project under the Asia Pacific Vaccine Access Facility | ADB SPF CRP | Sri Lanka | 30/06/2021 | Closed Without Outputs |